N-(1,1-dimethylethyl)-3,5-dimethyl-2-pyridine carboxamide | 117850-13-2

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡啶及其衍生物
• 英文名称: N-(1,1-dimethylethyl)-3,5-dimethyl-2-pyridine carboxamide
• 英文别名: N-(1,1-dimethylethyl)-3,5-dimethyl-2-pyridinecarboxamide；N-tert-butyl-3,5-dimethylpyridine-2-carboxamide
• CAS: 117850-13-2
• 化学式: C₁₂H₁₈N₂O
• 分子量: 206.288
• InChiKey: WLAUSNCXMJIKJF-UHFFFAOYSA-N

物化性质

• 沸点：
  331.5±42.0 °C(Predicted)
• 密度：
  1.005±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.2
• 重原子数：
  15
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.5
• 拓扑面积：
  42
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  1-(Bromomethyl)-2-chloro-5-methoxy-3-methylbenzene 、 N-(1,1-dimethylethyl)-3,5-dimethyl-2-pyridine carboxamide 在 lithium diisopropyl amide 作用下， 生成 N-tert-butyl-3-[2-(2-chloro-5-methoxy-3-methylphenyl)ethyl]-5-methylpyridine-2-carboxamide
  参考文献：
  名称：

  Analogs of 4-(3-bromo-8-methyl-10-methoxy-6,11-dihydro-5H-benzo[5,6]-cyclohepta[1,2-b]pyridin-11-yl)-1-(4-pyridinylacetyl)piperidine N-oxide as inhibitors of farnesyl protein transferase

  摘要：

  A series of 3-substituted analogs 3 of 4-(3-bromo-8-methyl-10-methoxy-6,11-dihydro-5H-benzo[5,6]-cyclohepta[1,2b]pyridin-11-yl)-1-(4-pyridinylacetyl)piperidine N-oxide 2 was prepared and evaluated as FPT inhibitors. The objective of this study was to identify other substituents at C-3 in this series of FPT inhibitors that would have the FPT potency enhancement similar to that found for a C-3 bromo substituent. The 3-methyl analog 17b was found to be tenfold less active than 2, and other C-3 substituents having more steric bulk were found to cause a further reduction in activity, (C) 1999 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0960-894x(99)00287-5
• 作为产物：
  描述：

  2-氰基-3,5-二甲基吡啶 以 conc. H2 SO4 、 叔丁醇 为溶剂， 生成 N-(1,1-dimethylethyl)-3,5-dimethyl-2-pyridine carboxamide
  参考文献：
  名称：

  Tricyclic carbamate compounds useful for inhibition of G-protein

  摘要：

  公开了一种抑制Ras功能从而抑制细胞生长的方法。该方法包括施用公式1.0的化合物。 ##STR1## 还公开了以下新化合物：##STR2## 还公开了用于制造1.1、1.2和1.3号化合物中3-取代衍生物的过程。进一步公开了在制造1.1、1.2和1.3号化合物中3-取代衍生物的过程中作为中间体使用的新化合物。

  公开号：

  US05721236A1

文献信息

• Benzo[5,6]cycloheptapyridine compounds, compositions and method of
  申请人：Schering Corporation

  公开号：US05089496A1

  公开（公告）日：1992-02-18

  Derivatives of benzo[5,6]cyclohepta pyridine, and pharmaceutically acceptable salts and solvates thereof are disclosed, which possess anti-allergic and anti-inflammatory activity. Methods for preparing and using the compounds are also described.

  苯并[5,6]环庚哌啶的衍生物，以及其药用可接受的盐和溶剂化合物被披露，具有抗过敏和抗炎活性。还描述了制备和使用这些化合物的方法。
• Tricyclic amide and urea compounds useful for inhibition of G-protein
  申请人：Schering Corporation

  公开号：US05700806A1

  公开（公告）日：1997-12-23

  Novel compounds of Formula (7.0a), (7.0b) or (7.0c): ##STR1## are disclosed. Also disclosed is a method of inhibiting Ras function and therefore inhibiting the abnormal growth of cells. The method comprises administering a compound of the formula (7.0a), (7.0b) or (7.0c) to a biological system. In particular, the method inhibits the abnormal growth of cells in a mammal such as a human being.

  揭示了化合物的新颖结构，其化学式为(7.0a)、(7.0b)或(7.0c)：##STR1##。还揭示了一种抑制Ras功能从而抑制细胞异常生长的方法。该方法包括向生物系统施用化合物的化学式(7.0a)、(7.0b)或(7.0c)。具体而言，该方法抑制了哺乳动物（如人类）中细胞的异常生长。
• Tricyclic amide and urea compounds useful for inhibition of g-protein
  申请人：Schering Corporation

  公开号：US05719148A1

  公开（公告）日：1998-02-17

  A method of inhibiting Ras function and therefore inhibiting the abnormal growth of cells is disclosed. The method comprises the administration of a compound of Formula 1.0: ##STR1## to a biological system. In particular, the method inhibits the abnormal growth of cells in a mammal such as a human being. Novel compounds of formulas 5.0, 5.1 and 5.2, wherein R is --C(R.sup.20)(R.sup.21)(R.sup.46), and 5.3, 5.3A and 5.3B, wherein R is --N(R.sup.25)(R.sup.48), are disclosed. Also disclosed are processes for making 3-substituted compounds of Formulas 5.0, 5.1, 5.2 and 5.3. Further disclosed are novel compounds which are intermediates in the process for making 3-substituted compounds of Formulas 5.0, 5.1, 5.2 and 5.3.

  抑制Ras功能从而抑制细胞异常生长的方法已被披露。该方法包括向生物系统中施用Formula 1.0的化合物：##STR1##。具体来说，该方法抑制了哺乳动物（如人类）中细胞的异常生长。还披露了Formula 5.0、5.1和5.2的新化合物，其中R为--C(R.sup.20)(R.sup.21)(R.sup.46)，以及Formula 5.3、5.3A和5.3B，其中R为--N(R.sup.25)(R.sup.48)。还披露了制备Formula 5.0、5.1、5.2和5.3的3-取代化合物的方法。此外，还披露了在制备Formula 5.0、5.1、5.2和5.3的3-取代化合物过程中的中间体新化合物。
• Bis-benzo or benzopyrido cyclohepta piperidene, piperidylidene and
  申请人：Schering Corporation

  公开号：US05422351A1

  公开（公告）日：1995-06-06

  Bis-benzo or benzopyrido piperidene, piperidylidene and piperazine compounds of the formula: ##STR1## and pharmaceutically acceptable salts thereof are disclosed, wherein Z represents --(C(R.sup.a).sub.2).sub.m --Y--(C(R.sup.a).sub.2).sub.n -- or ##STR2## The compounds of Formula I possess anti-allergic and anti-inflammatory activity. Methods for preparing and using the compounds are also described.

  本发明揭示了一种具有以下结构的双苯或苯并吡啶哌啶烯，哌啶基亚甲基和哌嗪类化合物的药用盐：其中Z代表--(C(R^a)_2)_m--Y--(C(R^a)_2)_n--或##STR2##。式I的化合物具有抗过敏和抗炎活性。还描述了制备和使用这些化合物的方法。
• Heterocyclic n-oxide derivatives of substituted
  申请人：Schering Corporation

  公开号：US05151423A1

  公开（公告）日：1992-09-29

  Heterocyclic N-oxide derivatives of substituted benzo[5,6]cycloheptapyridines, and pharmaceutically acceptable salts and solvates thereof are disclosed, which possess anti-allergic and anti-inflammatory activity. Methods for preparing and using the compounds are also described.

  本文披露了替代苯并[5,6]环庚七吡啶的杂环N-氧化物衍生物，以及其药用可接受的盐和溶剂化合物，具有抗过敏和抗炎活性。还描述了制备和使用这些化合物的方法。